Wednesday, April 18, 2018 10:53:42 AM
20180417|PCFP|1500|0|6751|O
20180416|PCFP|8500|0|12339|O
20180412|PCFP|500|0|5064|O
20180411|PCFP|934|0|13325|O
20180410|PCFP|5500|0|13440|O
20180406|PCFP|5000|0|7935|O
20180405|PCFP|400|0|3508|O
20180404|PCFP|8500|0|28476|O
20180403|PCFP|12181|0|18553|O
20180402|PCFP|11769|0|40792|O
http://regsho.finra.org/FORFshvol20180402.txt
$FUTL
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM